|
|
ADMET 2010 conference has become a crucial show for those working in the drug development process. The aim of the event is to aid in the removal of weak drug candidates early in the drug-discovery process. This conference is all set to offer opportunities for the attendees to discover most recent development, technologies and techniques used in the industry. The 5th edition of this event will showcase a striking mix of industry-led keynotes, interactive panels, workshops and crucial networking opportunities for the participants. During the event participants will learn about the tools and strategies involved in characterising and scrutinizing hepatotoxicity. They would also get exposure to the application of High Content Analysis for analytical cytotoxicity testing & preclinical toxicity biomarkers.
Visitor Profile
The targeted visitors at the ADMET 2010 would include Team Leaders, Senior Scientists, CEOs, Presidents, Heads, Directors, CSOs, CMOs, and Vice Presidents associated with:
- DMPK
- Pharmacokinetics
- Toxicology / metabolism
- Computational Chemistry
- Bimolecular Screening
- Drug Discovery
- Lead Optimization
- Screening and Lead Characterization
- Medicinal Chemistry
- Preclinical Development
- ADME
- Structural Biologists
- Drug Design
- Cheminformatics
- Molecular Modeling
- Physical Chemistry
Organizer
SMi
